These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35402560)

  • 1. Associations of ATP-Sensitive Potassium Channel's Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes.
    Liu C; Lai Y; Guan T; Zhan J; Pei J; Wu D; Ying S; Shen Y
    Front Cardiovasc Med; 2022; 9():816847. PubMed ID: 35402560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of KATP Gene Polymorphisms with Dyslipidemia and Ischemic Stroke Risks Among Hypertensive Patients in South China.
    Liu C; Guan T; Lai Y; Shen Y
    J Mol Neurosci; 2021 Oct; 71(10):2142-2151. PubMed ID: 33400071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP-sensitive potassium channels gene polymorphism rs1799858 affects the risk of macro-/micro-vascular arteriosclerotic event in patients with increased low-density lipoprotein cholesterol levels.
    Liu C; Guan T; Lai Y; Zhu J; Kuang J; Shen Y
    Lipids Health Dis; 2020 Jun; 19(1):147. PubMed ID: 32576189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of KATP Variants With CMD and RAP in CAD Patients With Increased Serum Lipoprotein(a) Levels.
    Pei J; Liu C; Yang Z; Lai Y; Zhang S; Guan T; Shen Y
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1061-1074. PubMed ID: 36469795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genetic Analysis of KATP Variants With Heart Failure Risk in Patients With Decreased Serum ApoA-I Levels.
    Liu C; Lai Y; Pei J; Huang H; Zhan J; Ying S; Shen Y
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2264-2278. PubMed ID: 33982099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma exosome-derived microRNAs expression profiling and bioinformatics analysis under cross-talk between increased low-density lipoprotein cholesterol level and ATP-sensitive potassium channels variant rs1799858.
    Liu C; Lai Y; Ying S; Zhan J; Shen Y
    J Transl Med; 2020 Dec; 18(1):459. PubMed ID: 33272292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition and bioinformatics analysis of ATP-sensitive potassium channels polymorphisms with the risks of elevated apolipoprotein B serum levels and its related arteriosclerosis cardiovascular disease.
    Liu C; Guan T; Lai Y; Zhan J; Shen Y
    Aging (Albany NY); 2021 Mar; 13(6):8177-8203. PubMed ID: 33686948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ACE2 variant rs4646188 with the risks of atrial fibrillation and cardioembolic stroke in Uygur patients with type 2 diabetes.
    Liu C; Pei J; Lai Y; Guan T; Zeyaweiding A; Maimaiti T; Zhao H; Shen Y
    BMC Cardiovasc Disord; 2021 Feb; 21(1):103. PubMed ID: 33602129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.
    Xu J; Hao X; Zhan R; Jiang X; Jin A; Xue J; Cheng A; Liu J; Lin J; Meng X; Li H; Zheng L; Wang Y
    Stroke; 2022 Aug; 53(8):2504-2511. PubMed ID: 35410491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.
    Polovina M; Lund LH; Đikić D; Petrović-Đorđević I; Krljanac G; Milinković I; Veljić I; Piepoli MF; Rosano GMC; Ristić AD; Ašanin M; Seferović PM
    Eur J Heart Fail; 2020 Jan; 22(1):113-125. PubMed ID: 31822042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China.
    Pan Y; Wang T; Li Y; Guan T; Lai Y; Shen Y; Zeyaweiding A; Maimaiti T; Li F; Zhao H; Liu C
    Lipids Health Dis; 2018 Oct; 17(1):241. PubMed ID: 30342552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U; Dahlström U; Fu M; Lund LH
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A5 gene promoter region-1131T/C polymorphism is associated with risk of ischemic stroke and elevated triglyceride levels: a meta-analysis.
    Pi Y; Zhang L; Yang Q; Li B; Guo L; Fang C; Gao C; Wang J; Xiang J; Li J
    Cerebrovasc Dis; 2012; 33(6):558-65. PubMed ID: 22688093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type of Atrial Fibrillation and Outcomes in Patients With Heart Failure and Reduced Ejection Fraction.
    Mogensen UM; Jhund PS; Abraham WT; Desai AS; Dickstein K; Packer M; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Køber L; McMurray JJV;
    J Am Coll Cardiol; 2017 Nov; 70(20):2490-2500. PubMed ID: 29145948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic power of left atrial strain in patients with acute heart failure.
    Park JH; Hwang IC; Park JJ; Park JB; Cho GY
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(2):210-219. PubMed ID: 32031588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    Ference BA; Kastelein JJP; Ray KK; Ginsberg HN; Chapman MJ; Packard CJ; Laufs U; Oliver-Williams C; Wood AM; Butterworth AS; Di Angelantonio E; Danesh J; Nicholls SJ; Bhatt DL; Sabatine MS; Catapano AL
    JAMA; 2019 Jan; 321(4):364-373. PubMed ID: 30694319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.
    Mani P; Puri R; Schwartz GG; Nissen SE; Shao M; Kastelein JJP; Menon V; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2019 Apr; 4(4):314-320. PubMed ID: 30840024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Unfavorable Outcomes in Patients with Atrial Fibrillation and Concomitant Heart Failure with Different Ejection Fractions: RIF-CHF Register One-Year Follow-Up.
    Zhirov I; Safronova N; Osmolovskaya Y; Alshevskaya A; Moskalev A; Tereshchenko S
    Cardiol Res Pract; 2019; 2019():1692104. PubMed ID: 31223501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.